Pardes Biosciences Stock Shares Owned By Insiders
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Pardes Biosciences fundamentals help investors to digest information that contributes to Pardes Biosciences' financial success or failures. It also enables traders to predict the movement of Pardes Stock. The fundamental analysis module provides a way to measure Pardes Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pardes Biosciences stock.
Pardes |
Pardes Biosciences Company Shares Owned By Insiders Analysis
Pardes Biosciences' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Pardes Biosciences Shares Owned By Insiders | 13.47 % |
Most of Pardes Biosciences' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pardes Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 13.47% of Pardes Biosciences are shares owned by insiders. This is 11.26% lower than that of the Biotechnology sector and 5.01% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 33.5% lower than that of the firm.
Pardes Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pardes Biosciences' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pardes Biosciences could also be used in its relative valuation, which is a method of valuing Pardes Biosciences by comparing valuation metrics of similar companies.Pardes Biosciences is currently under evaluation in shares owned by insiders category among its peers.
Pardes Fundamentals
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Shares Owned By Insiders | 13.47 % | |||
| Shares Owned By Institutions | 72.05 % | |||
| Number Of Shares Shorted | 874.35 K | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Net Income | (96.63 M) | |||
| Cash And Equivalents | 228.6 M | |||
| Cash Per Share | 3.67 X | |||
| Current Ratio | 20.84 X | |||
| Book Value Per Share | 2.57 X | |||
| Cash Flow From Operations | (71.98 M) | |||
| Short Ratio | 1.09 X | |||
| Earnings Per Share | (1.28) X | |||
| Target Price | 1.25 | |||
| Number Of Employees | 57 | |||
| Beta | 0.42 | |||
| Market Capitalization | 133.95 M | |||
| Total Asset | 200.62 M | |||
| Retained Earnings | (148.16 M) | |||
| Working Capital | 179.98 M | |||
| Z Score | -1.6 | |||
| Net Asset | 200.62 M |
About Pardes Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pardes Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pardes Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pardes Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |